Mathematical formulation of additivity for antimicrobial agents

Diagnostic Microbiology and Infectious Disease

Volumn 55, Issue 4, 2006, Pages 319-325

  Boucher, Adam N ^a   Tam, Vincent H ^b  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Additivity; Antagonism; Combination therapy; Drug interaction; Isobol; Response surface; Synergy

Indexed keywords

ANTIINFECTIVE AGENT;

ANALYTIC METHOD; ARTICLE; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG POTENTIATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NULL HYPOTHESIS; PRIORITY JOURNAL; RESPONSE SURFACE METHOD;

ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MODELS, BIOLOGICAL;

EID: 33746385855     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.01.024     Document Type: Article

References (12)

1. Berenbaum M.C. The expected effect of a combination of agents: the general solution. J. Theor. Biol. 114 (1985) 413-431
2. Berenbaum M.C. What is synergy?. Pharmacol. Rev. 41 (1989) 93-141
3. Bliss C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26 (1939) 585-615
4. Greco W.R., Bravo G., and Parsons J.C. The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47 (1995) 331-385
5. Greco W.R., Park H.S., and Rustum Y.M. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-d-arabinofuranosylcytosine. Cancer Res. 50 (1990) 5318-5327
6. Karakoc B., and Gerceker A.A. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 18 (2001) 567-570
7. King T.C., Schlessinger D., and Krogstad D.J. The assessment of antimicrobial combinations. Rev. Infect. Dis. 3 (1981) 627-633
8. Meletiadis J., Mouton J.W., Meis J.F., and Verweij P.E. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47 (2003) 106-117
9. Perea S., Gonzalez G., Fothergill A.W., Kirkpatrick W.R., Rinaldi M.G., and Patterson T.F. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 46 (2002) 3039-3041
10. Rochon-Edouard S., Pestel-Caron M., Lemeland J.F., and Caron F. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 44 (2000) 3055-3060
11. Tam V.H., Schilling A.N., Lewis R.E., Melnick D.A., and Boucher A.N. Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents. Antimicrob. Agents Chemother. 48 (2004) 4315-4321
12. Te Dorsthorst D.T., Verweij P.E., Meletiadis J., Bergervoet M., Punt N.C., Meis J.F., and Mouton J.W. In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach. Antimicrob. Agents Chemother. 46 (2002) 2982-2989